Literature DB >> 7175502

Analysis and purification of human lymphoblastoid (Namalwa) interferon using a monoclonal antibody.

G Allen, K H Fantes, D C Burke, J Morser.   

Abstract

Highly purified interferon-alpha (IFN-alpha) prepared from a human lymphoblastoid line (Namalwa) was analysed by gel filtration and polyacrylamide gel electrophoresis (PAGE). Gel filtration separated the IFN-alpha into two peaks (A and B). All the components of peak A were retained by a monoclonal antibody (NK2) column, but some of those from peak B were not retained. The IFN that was not bound was active on mouse cells and could be resolved into two major bands by PAGE. The bound fraction (about 75% of the interferon protein) was purified by means of the monoclonal antibody column, although complete purification of crude interferon was not achieved in one passage.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7175502     DOI: 10.1099/0022-1317-63-1-207

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  STAT1 from the cell membrane to the DNA.

Authors:  B F Lillemeier; M Köster; I M Kerr
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene.

Authors:  A M Ackrill; G R Foster; C D Laxton; D M Flavell; G R Stark; I M Kerr
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

3.  Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons.

Authors:  J John; R McKendry; S Pellegrini; D Flavell; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Differential response of the human 6-16 and 9-27 genes to alpha and gamma interferons.

Authors:  A M Ackrill; L E Reid; C S Gilbert; D R Gewert; A C Porter; A R Lewin; G R Stark; I M Kerr
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

5.  Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells.

Authors:  A P Rice; R Duncan; J W Hershey; I M Kerr
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells.

Authors:  T C Dale; A M Imam; I M Kerr; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

7.  2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.

Authors:  A P Rice; W K Roberts; I M Kerr
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway.

Authors:  S Pellegrini; J John; M Shearer; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

9.  Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.

Authors:  J M Pelham; J D Gray; G R Flannery; M V Pimm; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

10.  Receptor mediated pathways for interferon action: in vivo implications.

Authors:  K E Mogensen; M T Bandu; F Vignaux; G Uze; P Eid
Journal:  Med Oncol Tumor Pharmacother       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.